Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.94 USD | +21.08% | +15.15% | -45.11% |
Business Summary
Number of employees: 7
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stephen Glover
CEO | Chief Executive Officer | 60 | 01/14/01 |
Peter Wolfe
DFI | Director of Finance/CFO | 56 | 12/22/12 |
Pablo Guzman
CTO | Chief Tech/Sci/R&D Officer | 74 | 01/23/01 |
Karen Cashmere
PRN | Corporate Officer/Principal | 71 | 12/22/12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Glover
CEO | Chief Executive Officer | 60 | 01/14/01 |
Robert Finizio
BRD | Director/Board Member | 53 | 01/22/01 |
James Sapirstein
BRD | Director/Board Member | 63 | 05/23/05 |
Gregory Freitag
BRD | Director/Board Member | 62 | 05/23/05 |
Min-Chul Park
BRD | Director/Board Member | 42 | 01/22/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 5,062 | 0 | 0 | 99.24 % |
Stock B | 1 | 834,902 | 828,597 ( 99.24 %) | 6 ( 0.000743 %) | |
Stock C | 0 | 50 | 0 | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.11% | 3.1M | |
+11.91% | 114B | |
+11.60% | 105B | |
-4.68% | 23.83B | |
-0.82% | 21.73B | |
-10.12% | 18.1B | |
-42.12% | 16.34B | |
-17.47% | 16.13B | |
+2.77% | 13.75B | |
+34.58% | 11.76B |
- Stock Market
- Equities
- ZVSA Stock
- Company ZyVersa Therapeutics, Inc.